KRAS and colorectal cancer: ,, For follow-up experiments,we used the WNT- and KRAS-dependent human colorectal cancer cell lineSW620, which we have previously shown to be responsive to Mediatorkinase inhibition in vitro and in vivo (Supporting Figure S1).,,